Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Neelkanthi Churna: Neelkanthi Churna 3 g twice a day orally for 12 weeks duration
Control Intervention1: Tab. Metformin: Tab. Metformin 1 g Twice a day orally for 12 weeks
Sponsors
Principal
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients of either sex aged between 20-70yrs. 2) Newly diagnosed patients of Type 2 Diabetes Mellitus having glycosylated Hb (HbA1C) between 6.5% to 10% 3) Patients willing to participate in the trial.
Exclusion criteria
Exclusion criteria: Subject of Type-1 DM or Type-2 DM on insulin/OHAââ?¬•s other than Metformin/ any other medication for glucose control in the last 3 months Subjects suffering from the complications of Diabetes Mellitus viz., diabetic neuropathy, diabetic nephropathy, diabetic retinopathy etc. which require an urgent treatment. Patients having major medical illness like cancer, concurrent infection like tuberculosis. Patients with uncontrolled Hypertension. Patients with established diagnosis of CAD or any other clinically significant cardiovascular disease. Renal dysfunction (defined by eGFR Subjects who have completed participation in any other clinical trial during the past 3 months. Any other condition which the investigator thinks may compromise the safety of subject. Subjects with Haemoglobin percentage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fulfillment of objective and subjective criteriaTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy of Neelkanthi Churna in type 2 Diabetes MellitusTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactShivali Mehra
R G G P G Ayurvedic College and Hospital
Outcome results
None listed